Functional plasticity in human FOXP3+ regulatory T cells: Implications for cell-based immunotherapy

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 7, 2012, Pages 1001-1005

  D'Hennezel, Eva ^a,b   Piccirillo, Ciriaco A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOACCUMULATION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CORD BLOOD STEM CELL TRANSPLANTATION; DOWN REGULATION; EX VIVO STUDY; FOXP3+ REGULATORY T LYMPHOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PATIENT SAFETY; PLASTICITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; TRANSCRIPTION REGULATION; ANIMAL; CHEMISTRY; IMMUNOLOGY; METHODOLOGY; REVIEW; RODENT;

ANIMALS; ANTIGENS, CD4; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOTHERAPY; RODENTIA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84864051274     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.20203     Document Type: Article

References (35)

1. Levings MK, Allan S, d'Hennezel E, Piccirillo CA. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv Immunol 2006; 92:119-55; PMID:17145303; http://dx.doi.org/10.1016/S0065-2776(06)92003-3
2. Chen W, JinW, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875-86; PMID:14676299; http://dx.doi.org/10.1084/jem.20030152
3. Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007; 5:e38; PMID: 17298177; http://dx.doi.org/10.1371/journal.pbio.0050038
4. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330-6; PMID: 12612578; http://dx.doi.org/10.1038/ni904
5. Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 2008; 57:113-23; PMID:17928397; http://dx.doi.org/10.2337/db06-1700
6. Bacchetta R, Gambineri E, Roncarolo MG. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 2007; 120:227-35, quiz 236-7; PMID:17666212; http://dx.doi.org/10.1016/j.jaci.2007.06.023
7. Long SA, Buckner JH. CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game. J Immunol 2011; 187:2061-6; PMID:21856944; http://dx.doi.org/10.4049/jimmunol.1003224
8. Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res 2010; 20:4-12; PMID:20010916; http://dx.doi.org/10.1038/cr.2009.138
9. Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S. Heterogeneity of natural Foxp3 + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 2009; 106:1903-8; PMID: 19174509; http://dx.doi.org/10.1073/pnas.0811556106
10. Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, et al. Inflammation-driven reprogramming of CD4+Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PloS one 2012; 7:e35572.
11. Feuerer M, Hill JA, Kretschmer K, von Boehmer H, Mathis D, Benoist C. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc Natl Acad Sci U S A 2010; 107:5919-24; PMID:20231436; http://dx.doi.org/10.1073/ pnas.1002006107
12. Hori S. Stability of regulatory T-cell lineage. Adv Immunol 2011; 112:1-24; PMID:22118405; http://dx.doi.org/10.1016/B978-0-12-387827-4.00001-2
13. Hoffmann P, Boeld TJ, Eder R, Huehn J, Floess S, Wieczorek G, et al. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009; 39:1088-97; PMID:19283780; http://dx.doi.org/10.1002/eji.200838904
14. d'Hennezel E, Yurchenko E, Sgouroudis E, Hay V, Piccirillo CA. Single-cell analysis of the human T regulatory population uncovers functional heterogeneity and instability within FOXP3+ cells. J Immunol 2011; 186:6788-97; PMID:21576508; http://dx.doi.org/10.4049/jimmunol.1100269
15. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30:899-911; PMID:19464196; http://dx.doi.org/10.1016/j.immuni.2009.03.019
16. Beyer M, Schultze JL. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3? Int Immunopharmacol 2011; 11:555-60; PMID:21115121; http://dx.doi.org/10.1016/j.intimp.2010.11.024
17. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002; 346:1692-8; PMID:12037148; http://dx.doi.org/10.1056/ NEJMoa012864
18. Casares S, Hurtado A, McEvoy RC, Sarukhan A, von Boehmer H, Brumeanu TD. Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera. Nat Immunol 2002; 3:383-91; PMID:11862219; http://dx.doi.org/10.1038/ni770
19. Tisch R, Liblau RS, Yang XD, Liblau P, McDevitt HO. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 1998; 47:894-9; PMID:9604865; http://dx.doi.org/10.2337/diabetes.47.6.894
20. Peron JP, Yang K, Chen ML, Brandao WN, Basso AS, Commodaro AG, et al. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice. J Neuroimmunol 2010; 227:10-7; PMID:20580440; http://dx.doi.org/10.1016/j.jneuroim.2010.06.002
21. Lavasani S, Dzhambazov B, Nouri M, Fåk F, Buske S, Molin G, et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 2010; 5:e9009; PMID:20126401; http://dx.doi.org/10.1371/journal.pone.0009009
22. Battaglia M, Roncarolo MG. Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes. Semin Immunol 2011; 23:182-94; PMID:21831659; http://dx.doi.org/10.1016/j.smim.2011.07.007
23. Noris M, Casiraghi F, Todeschini M, Cravedi P, Cugini D, Monteferrante G, et al. Regulatory T cells and T cell depletion: role of immunosuppressive drugs. J Am Soc Nephrol 2007; 18:1007-18; PMID:17287424; http://dx.doi.org/10. 1681/ASN.2006101143
24. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008; 9:239-44; PMID:18285775; http://dx.doi.org/10.1038/ni1572
25. d'Hennezel E, Kornete M, Piccirillo CA. IL-2 as a therapeutic target for the restoration of Foxp3+ regulatory T cell function in organ-specific autoimmunity: implications in pathophysiology and translation to human disease. J Transl Med 2010; 8:113; PMID:21059266; http://dx.doi.org/10.1186/1479-5876-8- 113
26. Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, et al. CD4+ T-regulatory cells: toward therapy for human diseases. Immunol Rev 2008; 223:391-421; PMID:18613849; http://dx.doi.org/10.1111/j.1600-065X.2008.00634.x
27. Miyara M, Wing K, Sakaguchi S. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J Allergy Clin Immunol 2009; 123:749-55, quiz 756-7; PMID:19348913; http://dx.doi.org/10.1016/j.jaci. 2009.03.001
28. Allan SE, Song-Zhao GX, Abraham T, McMurchy AN, Levings MK. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 2008; 38:3282-9; PMID: 19039775; http://dx.doi.org/10. 1002/eji.200838373
29. Shevach EM, Davidson TS, Huter EN, Dipaolo RA, Andersson J. Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function. J Clin Immunol 2008; 28:640-6; PMID:18810612; http://dx.doi.org/10.1007/s10875- 008-9240-1
30. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204:1775-85; PMID: 17620362; http://dx.doi.org/10.1084/jem.20070602
31. Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, et al. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 2008; 111:453-62; PMID:17967941; http://dx.doi.org/10.1182/blood-2007-06- 094482
32. Vukmanovic-Stejic M, Zhang Y, Cook JE, Fletcher JM, McQuaid A, Masters JE, et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006; 116:2423-33; PMID:16955142; http://dx.doi.org/10.1172/JCI28941
33. Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011; 117:1061-70; PMID:20952687; http://dx.doi.org/10.1182/blood-2010-07-293795
34. Lal G, Zhang N, van der Touw W, Ding Y, Ju W, Bottinger EP, et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 2009; 182:259-73; PMID:19109157
35. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2009; 301:1573-9; PMID:19366777; http://dx.doi.org/ 10.1001/jama.2009.470